Blow For Sandoz And Boehringer As PBM OptumRx Deletes Humira Biosimilars

Amgen’s Amjevita Will Remain As Tier Two Product; Humira Brand Is Tier Three

 
• By Dean Rudge
  
• Source: Shutterstock (Shutterstock)

More from Biosimilars

More from Generics Bulletin